ABL Bio

GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier

GSK is licensing an ABL Bio technology that yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimer’s disease.

By Frank Vinluan

BioPharma, Pharma

Sanofi shores up neuro pipeline with deal for brain-penetrating Parkinson’s drug

Sanofi is the latest company to strike a deal for a Parkinson’s disease drug candidate that targets the protein alpha synuclein. The asset from ABL Bio is a bispecific antibody designed to penetrate the blood-brain barrier.

By Frank Vinluan

Immune Support on Demand: Ranking the Top Mobile IV Therapy Companies

Explore the top mobile IV therapy companies boosting immune health on demand, with standout services, expert care and innovative delivery across the U.S.

By Lone Star IV Medics

These Are the Top-Rated Autism Therapy Centers in Texas

There are a number of criteria for selecting the best autism therapy centers. Parents choosing a facility or professionals seeking to improve their offerings should consider certain standards to ensure the right fit.

By Behavioral Innovations

Simplify Salon & Spa Employee Management with Meevo’s Comprehensive Software

Meevo offers an all-in-one solution for managing salon and spa employees. From scheduling and time tracking to payroll and promotions, Meevo streamlines operations and supports growth.

By Meevo